Amgen Inc (AMGN)

Xetra


	Symbol		Exchange		Currency
	AMGN		NASDAQ		USD	Real-time
	AMGN		Mexico		MXN	Delayed
	AMGN		BIVA		MXN	Delayed
	AAMGN		Milan		EUR	Real-time
	AMGN		TradeGate		EUR	Delayed
	AMGN		Xetra		EUR	Delayed
	AMGN		Frankfurt		EUR	Delayed
	AMGNm		Buenos Aires		ARS	Delayed
	AMGN34		B3		BRL	Delayed
	AMGN		Vienna		EUR	Real-time
	AMGN		Lima		USD	Delayed

Currency in EUR

Disclaimer

289.20

+0.40(+0.14%)

Closed03/10

Fair Value

Day's Range

287.30

289.20

52 wk Range

237.00

318.05

AMGN Income Statement

Featured here, the Income Statement (earnings report) for Amgen Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

23,362

25,424

25,979

26,323

28,190

Total Revenues Growth

-1.62%

+8.83%

+2.18%

+1.32%

+7.09%

Cost Of Revenues

4,356

6,159

6,454

6,406

8,415

Gross Profit

19,006

19,265

19,525

19,917

19,775

Gross Profit Growth

-3.26%

+1.36%

+1.35%

+2.01%

-0.71%

Gross Profit Margin %

81.35%

75.77%

75.16%

75.66%

70.15%

Other Operating Expenses, Total

9,266

9,937

10,381

9,848

11,611

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+1.88%	+7.24%	+4.47%	-5.13%	+17.9%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	4,116	4,207	4,819	4,434	4,755
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,150	5,730	5,368	5,414	6,166
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	194	-	690

Operating Income

9,740

9,328

9,144

10,069

8,164

Operating Income Growth

-7.69%

-4.23%

-1.97%

+10.12%

-18.92%

EBIT Margin %

41.69%

36.69%

35.2%

38.25%

28.96%

Net Interest Expenses

-1,289

-998

-1,197

-1,406

-2,875

Net Interest Expenses Growth

-571.35%

+22.58%

-19.94%

-17.46%

-104.48%

Interest Expense, Total

-1,289

-998

-1,197

-1,406

-2,875

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

697

297

733

-413

1,170

EBT, Excl. Unusual Items

9,148

8,627

8,680

8,250

6,459

Gain (Loss) On Sale Of Assets

-

-

-

-503

-

Other Unusual Items, Total

-

-189

-1,505

78

225

EBT, Incl. Unusual Items

9,138

8,133

6,701

7,346

7,855

EBT, Incl. Unusual Items Growth

-4.26%

-11%

-17.61%

+9.63%

+6.93%

EBT, Incl. Unusual Items Margin

39.11

31.99

25.79

27.91

27.86

Income Tax Expense

1,296

869

808

794

1,138

Net Income to Company

7,842

7,264

5,893

6,552

6,717

Minority Interest

-

-

-

-

-

Net Income

7,842

7,264

5,893

6,552

6,717

Net Income Growth

-6.58%

-7.37%

-18.87%

+11.18%

+2.52%

Net Income Margin %

33.57%

28.57%

22.68%

24.89%

23.83%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

7,842

7,264

5,893

6,552

6,717

Basic EPS - Continuing Operations

12.96

12.4

10.34

12.18

12.56

Basic EPS - Continuing Operations Growth

+2.07%

-4.37%

-16.6%

+17.8%

+3.09%

Diluted EPS - Continuing Operations

12.88

12.31

10.28

12.11

12.49

Diluted EPS - Continuing Operations Growth

+2.06%

-4.43%

-16.49%

+17.8%

+3.14%

Basic Weighted Average Shares Outstanding

605

586

570

538

535

Diluted Weighted Average Shares Outstanding

609

590

573

541

538

Dividend Per Share

5.8

6.4

7.04

7.76

8.52

Dividend Per Share Growth

+9.85%

+10.34%

+10%

+10.23%

+9.79%

EBITDA

11,775

12,929

12,542

13,486

12,235

EBITDA Growth

-5.66%

+9.8%

-2.99%

+7.53%

-9.28%